Imaging AI

Mergic Vision

Real-time GPU radiology and pathology AI for detection and segmentation across CT, MRI, X-ray, and whole-slide images.

Product capabilities

Real-time detection and segmentation across every imaging modality.

Mergic Vision connects scanners, PACS, and workstations into a GPU-accelerated detection loop with sub-second inference.

Scanner-side inference for urgent findings

Deploy Vision directly at the imaging edge using Holoscan for low-latency triage of critical findings — stroke, PE, pneumothorax — before images reach PACS.

Sub-second latency · GPU-native

MONAI segmentation workflows

Pre-trained and fine-tunable models for organs, lesions, and pathology regions with validated concordance.

Cross-modal context with Atlas

Link imaging findings to genomics, pathology, and EHR timelines for richer decision support.

Priority queue routing

Surface urgent findings at the top of radiologist work queues with confidence scores and evidence overlays.

Governed deployment via Citadel

VPC or on-prem with audit trails, model versioning, and PHI boundaries.

Continuous learning loop

Radiologist feedback flows back into Atlas for model retraining and performance compounding.

NVIDIA healthcare stack

Built natively on Clara, MONAI, and Holoscan.

Inference

NVIDIA Clara

GPU-accelerated medical imaging pipelines for detection, segmentation, and reconstruction.

Framework

MONAI

Open-source deep learning framework for medical imaging with pre-trained model zoo.

Edge

Holoscan

Low-latency sensor processing for operating rooms, imaging suites, and edge inference.

Performance metrics

Vision by the numbers.

<1s

Sub-second inference for urgent CT findings with Holoscan edge deployment

95%+

Sensitivity on stroke, PE, and pneumothorax detection tasks with validated models

40+

Imaging modalities supported: CT, MRI, X-ray, ultrasound, pathology slides

3x

Radiologist capacity increase without new hires via priority queue and triage automation

100%

Audit trail coverage for model predictions, escalations, and human signoff

How it works

From scanner to signoff in seconds.

Vision connects to your imaging infrastructure and applies GPU-accelerated models at every stage of the diagnostic pipeline.

Step 1

Ingest

Pull DICOM from scanners, PACS, or VNA via Holoscan edge or API

Step 2

Inference

Run MONAI models on NVIDIA GPUs for detection, segmentation, classification

Step 3

Triage

Route urgent findings to priority queues with confidence scores

Step 4

Context

Link to Atlas for genomics, pathology, EHR timeline context

Step 5

Review

Radiologist confirms, edits, or escalates via workbench or PACS overlay

Step 6

Learn

Feedback flows to Atlas for model retraining and performance improvement

Integration

Vision connects to your existing imaging stack.

PACS

DICOM ingest and push

Bi-directional DICOM connectivity to every major PACS vendor

Workstations

Overlay and worklist APIs

Inject findings into radiologist reading workflows via HL7, FHIR, or REST

EHR

Results delivery

Push structured reports and critical alerts to Epic, Cerner, or FHIR endpoints

FAQ

Questions before your demo.

Answers for radiology, IT, and compliance teams evaluating Vision.

Vision provides AI-assisted detection and triage for radiologist review. It is not a standalone diagnostic device. Final interpretation and signoff remain with licensed clinicians. Regulatory classification depends on deployment scope and intended use.

CT, MRI, X-ray, ultrasound, mammography, PET, and whole-slide pathology images. We support DICOM ingest and can fine-tune models for custom anatomies or protocols.

Yes. Vision runs in VPC, on-prem DGX, or hybrid configurations with full audit trails and PHI boundaries via Mergic Citadel.

Bi-directional DICOM connectivity, HL7 worklist integration, and REST APIs for overlay and structured reporting. We support all major PACS vendors.

Get started

See Vision in action with your imaging workflows.

Bring a radiology or pathology use case. We'll map the GPU architecture, PACS integration, and first measurable outcome.